↓ Skip to main content

Acetylcysteine and carbocysteine for acute upper and lower respiratory tract infections in paediatric patients without chronic broncho-pulmonary disease

Overview of attention for article published in Cochrane database of systematic reviews, May 2013
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (95th percentile)
  • High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

news
1 news outlet
blogs
1 blog
policy
1 policy source
twitter
14 tweeters
patent
1 patent
facebook
2 Facebook pages
wikipedia
1 Wikipedia page

Citations

dimensions_citation
18 Dimensions

Readers on

mendeley
136 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Acetylcysteine and carbocysteine for acute upper and lower respiratory tract infections in paediatric patients without chronic broncho-pulmonary disease
Published in
Cochrane database of systematic reviews, May 2013
DOI 10.1002/14651858.cd003124.pub4
Pubmed ID
Authors

Martin Chalumeau, Yvonne CM Duijvestijn

Abstract

Acetylcysteine and carbocysteine are the most commonly prescribed mucolytic drugs in Brazil and many European and African countries. To our knowledge, no systematic review has been published on their efficacy and safety for acute upper and lower respiratory tract infections (RTIs) in children without chronic broncho-pulmonary disease.

Twitter Demographics

The data shown below were collected from the profiles of 14 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 136 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Brazil 3 2%
Czechia 1 <1%
Netherlands 1 <1%
United Kingdom 1 <1%
Spain 1 <1%
United States 1 <1%
Unknown 128 94%

Demographic breakdown

Readers by professional status Count As %
Student > Master 22 16%
Other 20 15%
Researcher 18 13%
Student > Ph. D. Student 14 10%
Student > Bachelor 13 10%
Other 27 20%
Unknown 22 16%
Readers by discipline Count As %
Medicine and Dentistry 61 45%
Nursing and Health Professions 15 11%
Pharmacology, Toxicology and Pharmaceutical Science 9 7%
Agricultural and Biological Sciences 5 4%
Biochemistry, Genetics and Molecular Biology 4 3%
Other 11 8%
Unknown 31 23%

Attention Score in Context

This research output has an Altmetric Attention Score of 33. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 23 April 2020.
All research outputs
#683,827
of 16,165,977 outputs
Outputs from Cochrane database of systematic reviews
#1,828
of 11,415 outputs
Outputs of similar age
#8,215
of 171,345 outputs
Outputs of similar age from Cochrane database of systematic reviews
#19
of 110 outputs
Altmetric has tracked 16,165,977 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 95th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,415 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 23.9. This one has done well, scoring higher than 83% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 171,345 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 110 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 82% of its contemporaries.